K-numberK241982
Device nameDeepFoqus (DeepFoqus-Accelerate)
ApplicantFoqus Technologies, Inc.
Product codeQIH
Device classClass II
Decision dateApr 4, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

DeepFoqus-Accelerate is an AI-powered software system that reconstructs brain MRI images from accelerated (up to 4x undersampled) scans to produce clinical-quality images comparable to standard unaccelerated scans. It accepts DICOM and HDF5 files from 1.5T or 3T Siemens and GE MRI scanners for T1, T2, and FLAIR sequences in sagittal, axial, or coronal orientations, intended for adult use only by professional MRI/radiology staff.

Technological characteristics

The primary difference from the predicate device (SwiftMR) is the reconstruction algorithm: DeepFoqus-Accelerate uses ensembles of deep learning models (CNN and U-net architectures) to reconstruct accelerated image data, whereas SwiftMR uses convolutional neural network-based filtering for image enhancement. Both systems follow the same workflow (upload images, apply deep learning processing, export DICOM output) and neither directly interfaces with MRI equipment.

Test standards cited

ISO 14971:2019 (risk management), IEC 62366-1:2015+AMD1:2020 (usability), IEC 62304:2006/A1:2016 (software development), NEMA PS 3.1-3.20 2022d (DICOM standard), ISO 15223-1:2021 (labeling), AAMI TIR 57:2016, AAMI TIR 97:2019, and AAMI SW96:2023.

Substantial equivalence argument

Substantial equivalence is established through functional equivalence despite algorithmic differences. Both devices produce the same essential output (reconstructed/enhanced brain MRI images in DICOM format) for the same intended use. The algorithmic difference was validated through identical performance metrics (SSIM, PSNR, HaarPSI), phantom bench testing, artifact assessment, and clinical radiologist review—all showing comparable performance to the predicate. Direct comparison of major functionality demonstrated largely identical results, supporting that the different reconstruction methodology achieves equivalent clinical outcomes.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →